When an at-risk sleep apnea patient needed his breathing machine replaced, Lincare, a $2.4 billion behemoth with a decadeslong history of regulatory and legal problems, acted slowly. The result was ...

This article originally appeared on ProPublica. ProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like this one in your inbox.